924726-89-6 Usage
Description
Pregna-1,4-diene-3,20-dione, 6,9-difluoro-11,21-dihydroxy-16-methyl-17-(1-oxopropoxy)-, (6a,11b,16b)-, also known as Betamethasone Dipropionate, is a synthetic corticosteroid medication. It is characterized by its potent anti-inflammatory properties and is used to treat various skin conditions.
Used in Pharmaceutical Industry:
Pregna-1,4-diene-3,20-dione, 6,9-difluoro-11,21-dihydroxy-16-methyl-17-(1-oxopropoxy)-, (6a,11b,16b)is used as a topical corticosteroid for the treatment of skin conditions such as eczema, dermatitis, and psoriasis. It functions by reducing inflammation, redness, itching, and swelling, which are common symptoms of these conditions.
Used in Dermatology:
As a potent and effective corticosteroid, Pregna-1,4-diene-3,20-dione, 6,9-difluoro-11,21-dihydroxy-16-methyl-17-(1-oxopropoxy)-, (6a,11b,16b)is used in dermatology to manage skin inflammation and alleviate symptoms associated with various skin disorders. It is often found in topical creams, ointments, and lotions for external application.
Used in Anti-Inflammatory Treatments:
Pregna-1,4-diene-3,20-dione, 6,9-difluoro-11,21-dihydroxy-16-methyl-17-(1-oxopropoxy)-, (6a,11b,16b)is used as an anti-inflammatory agent to inhibit the production of inflammatory chemicals in the body. This action helps to control the immune response and reduce the severity of skin conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 924726-89-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,2,4,7,2 and 6 respectively; the second part has 2 digits, 8 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 924726-89:
(8*9)+(7*2)+(6*4)+(5*7)+(4*2)+(3*6)+(2*8)+(1*9)=196
196 % 10 = 6
So 924726-89-6 is a valid CAS Registry Number.
924726-89-6Relevant articles and documents
A PROCESS FOR PREPARING A CRYSTALLINE FORM OF HALOBETASOL PROPIONATE
-
Page/Page column 25, (2008/06/13)
The present invention provides a process for preparing a crystalline form of halobetasol propionate, comprising the step of crystallizing halobetasol propionate from absolute ethanol or a mixture of ethanol and water, wherein the crystalline form of halobetasol propionate is characterized by an x-ray powder diffraction pattern having peaks at 10.0, 11.6, 12.9, 13.4, 14.5, 16.4, 17.6, and 23.5 + 0.2 degrees 2θ.
